State Board of Administration of Florida Retirement System raised its stake in shares of Imperva Inc. (NYSE:IMPV) by 1.6% during the second quarter, Holdings Channel reports. The fund owned 17,640 shares of the company’s stock after buying an additional 277 shares during the period. State Board of Administration of Florida Retirement System owned 0.05% of Imperva worth $759,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in IMPV. Bank of Montreal Can acquired a new stake in Imperva during the second quarter valued at about $107,000. Legal & General Group Plc raised its stake in Imperva by 25.2% in the first quarter. Legal & General Group Plc now owns 6,964 shares of the company’s stock valued at $344,000 after buying an additional 1,403 shares during the last quarter. Prudential Financial Inc. raised its stake in Imperva by 102.4% in the first quarter. Prudential Financial Inc. now owns 6,991 shares of the company’s stock valued at $353,000 after buying an additional 3,537 shares during the last quarter. Quadrature Capital Ltd acquired a new stake in Imperva during the first quarter valued at about $358,000. Finally, Parametrica Management Ltd acquired a new stake in Imperva during the second quarter valued at about $396,000. 93.26% of the stock is owned by institutional investors and hedge funds.
Shares of Imperva Inc. (NYSE:IMPV) traded up 1.73% during trading on Friday, hitting $53.63. 785,313 shares of the stock were exchanged. Imperva Inc. has a 52 week low of $31.11 and a 52 week high of $77.99. The firm has a 50 day moving average price of $46.79 and a 200 day moving average price of $44.45. The firm’s market capitalization is $1.75 billion.
Imperva (NYSE:IMPV) last released its quarterly earnings data on Thursday, August 4th. The company reported ($0.23) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by $0.19. The business had revenue of $57.87 million for the quarter, compared to analysts’ expectations of $66.06 million. Imperva had a negative net margin of 23.75% and a negative return on equity of 25.68%. Imperva’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period last year, the company earned ($0.08) earnings per share. Analysts forecast that Imperva Inc. will post ($0.80) EPS for the current fiscal year.
Several equities research analysts recently issued reports on the stock. Deutsche Bank AG lowered shares of Imperva from a “buy” rating to a “hold” rating and reduced their price objective for the company from $45.00 to $43.00 in a research note on Tuesday, July 12th. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $60.00 target price on shares of Imperva in a research report on Tuesday, July 12th. BTIG Research reissued a “buy” rating and set a $55.00 target price on shares of Imperva in a research report on Monday, July 11th. Royal Bank Of Canada boosted their target price on shares of Imperva from $49.00 to $52.00 and gave the stock an “outperform” rating in a research report on Friday, August 5th. Finally, RBC Capital Markets reissued a “buy” rating and set a $52.00 target price (up previously from $49.00) on shares of Imperva in a research report on Friday, August 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and thirteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $53.33.
In other news, SVP Mark E. Kraynak sold 5,582 shares of the stock in a transaction dated Friday, September 23rd. The shares were sold at an average price of $51.00, for a total value of $284,682.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Amichai Shulman sold 3,085 shares of the stock in a transaction dated Thursday, September 15th. The stock was sold at an average price of $44.30, for a total transaction of $136,665.50. Following the completion of the sale, the insider now directly owns 94,147 shares in the company, valued at $4,170,712.10. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc. (NYSE:IMPV).
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.